Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract

por de Martel, C, Plummer, M, Parsonnet, J, van Doorn, L-J, Franceschi, S
Publicado 2009

First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study

por van Meerten, E, Eskens, F A L M, van Gameren, E C, Doorn, L, van der Gaast, A
Publicado 2007

Helicobacter Genotyping and Detection in Peroperative Lavage Fluid in Patients with Perforated Peptic Ulcer

por Komen, N. A. P., Bertleff, M. J. O. E., van Doorn, L. J., Lange, J. F., de Graaf, P. W.
Publicado 2007

Conjunctive therapy of cisplatin with the OCT2 inhibitor cimetidine: influence on antitumor efficacy and systemic clearance

por Sprowl, JA, van Doorn, L, Hu, S, van Gerven, L, de Bruijn, P, Li, L, Gibson, AA, Mathijssen, RH, Sparreboom, A
Publicado 2013

Human papillomavirus infection and squamous cell carcinoma of the conjunctiva

por Ateenyi-Agaba, C, Franceschi, S, Wabwire-Mangen, F, Arslan, A, Othieno, E, Binta-Kahwa, J, van Doorn, L-J, Kleter, B, Quint, W, Weiderpass, E
Publicado 2010

A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumours

por Eskens, F A L M, Tresca, P, Tosi, D, Van Doorn, L, Fontaine, H, Van der Gaast, A, Veyrat-Follet, C, Oprea, C, Hospitel, M, Dieras, V
Publicado 2014

Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1–5 of a 3-weekly cycle in patients with advanced solid tumours

por de Jonge, M J A, Kaye, S, Verweij, J, Brock, C, Reade, S, Scurr, M, van Doorn, L, Verheij, C, Loos, W, Brindley, C, Mistry, P, Cooper, M, Judson, I
Publicado 2004

Influence of OATP1B1 Function on the Disposition of Sorafenib‐β‐D‐Glucuronide

por Bins, S, van Doorn, L, Phelps, MA, Gibson, AA, Hu, S, Li, L, Vasilyeva, A, Du, G, Hamberg, P, Eskens, FALM, de Bruijn, P, Sparreboom, A, Mathijssen, RHJ, Baker, SD
Publicado 2017

A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off sc...

por Eskens, F A L M, Mom, C H, Planting, A S T, Gietema, J A, Amelsberg, A, Huisman, H, van Doorn, L, Burger, H, Stopfer, P, Verweij, J, de Vries, E G E
Publicado 2008

Multiple Norovirus Infections in a Birth Cohort in a Peruvian Periurban Community

por Saito, Mayuko, Goel-Apaza, Sonia, Espetia, Susan, Velasquez, Daniel, Cabrera, Lilia, Loli, Sebastian, Crabtree, Jean E., Black, Robert E., Kosek, Margaret, Checkley, William, Zimic, Mirko, Bern, Caryn, Cama, Vitaliano, Gilman, Robert H., Xiao, L., Kelleher, D., Windle, H. J., van Doorn, L. J., Varela, M., Verastegui, M., Calderon, M., Alva, A., Roman, K.
Publicado 2014

Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases – the multicenter randomi...

por Buisman, F. E., Homs, M. Y. V., Grünhagen, D. J., Filipe, W. F., Bennink, R. J., Besselink, M. G. H., Borel Rinkes, I. H. M., Bruijnen, R. C. G., Cercek, A., D’Angelica, M. I., van Delden, O. M., Donswijk, M. L., van Doorn, L., Doornebosch, P. G., Emmering, J., Erdmann, J. I., IJzerman, N. S., Grootscholten, C., Hagendoorn, J., Kemeny, N. E., Kingham, T. P., Klompenhouwer, E. G., Kok, N. F. M., Koolen, S., Kuhlmann, K. F. D., Kuiper, M. C., Lam, M. G. E., Mathijssen, R. H. J., Moelker, A., Oomen-de Hoop, E., Punt, C. J. A., te Riele, W. W., Roodhart, J. M. L., Swijnenburg, R. J., Prevoo, W., Tanis, P. J., Vermaas, M., Versleijen, M. W. J., Veuger, F. P., Weterman, M. J., Verhoef, C., Groot Koerkamp, B.
Publicado 2019